We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

107 hedge funds and large institutions have $804M invested in Bicycle Therapeutics in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

86% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 14

40% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 25

13% more funds holding

Funds holding: 95 → 107 (+12)

7.77% more ownership

Funds ownership: 80.5% → 88.27% (+7.8%)

6% more capital invested

Capital invested by funds: $759M → $804M (+$44.8M)

26% less call options, than puts

Call options by funds: $188K | Put options by funds: $255K

Holders
107
Holders Change
+12
Holders Change %
+12.63%
% of All Funds
1.55%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
26
Increased
35
Reduced
25
Closed
14
Calls
$188K
Puts
$255K
Net Calls
-$67K
Net Calls Change
-$326K

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$101M
2
FIS
FCPM III Services
Netherlands
+$48M
3
RCM
RA Capital Management
Massachusetts
+$32.8M
4
FFM
Fairmount Funds Management
Pennsylvania
+$24.2M
5
EC
EcoR1 Capital
California
+$20.6M

Top Sellers

Rank Fund Capital Flow
1
PBA
Paradigm Biocapital Advisors
New York
-$80.8M
2
SCM
Suvretta Capital Management
New York
-$22.8M
3
Morgan Stanley
Morgan Stanley
New York
-$6.44M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.42M
5
SSA
Schonfeld Strategic Advisors
New York
-$5.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
51
Wexford Capital
Florida
$908K +$226K +10,000 +29%
Skandinaviska Enskilda Banken (SEB)
52
Skandinaviska Enskilda Banken (SEB)
Sweden
$866K – – –
Millennium Management
53
Millennium Management
New York
$759K +$847K +37,507 New
Two Sigma Advisers
54
Two Sigma Advisers
New York
$625K -$355K -15,700 -34%
Allianz Asset Management
55
Allianz Asset Management
Germany
$619K – – –
JF
56
Jump Financial
Illinois
$586K +$655K +28,972 New
DekaBank Deutsche Girozentrale
57
DekaBank Deutsche Girozentrale
Germany
$582K – – –
Two Sigma Investments
58
Two Sigma Investments
New York
$538K -$45.2K -2,002 -7%
State Street
59
State Street
Massachusetts
$524K – – –
WC
60
Woodstock Corp
Massachusetts
$506K – – –
SCM
61
Soleus Capital Management
Connecticut
$476K -$2.93M -129,500 -85%
PI
62
PEAK6 Investments
Illinois
$445K +$294K +13,000 +144%
GGHC
63
Gilder Gagnon Howe & Co
New York
$438K +$8.81K +390 +2%
Geode Capital Management
64
Geode Capital Management
Massachusetts
$433K – – –
TAM
65
Tocqueville Asset Management
New York
$352K -$1.13K -50 -0.3%
NFGH
66
Nan Fung Group Holdings
Hong Kong
$350K +$391K +17,300 New
BG
67
Bellevue Group
Switzerland
$324K +$79.1K +3,500 +28%
UBS Group
68
UBS Group
Switzerland
$323K +$134K +5,953 +60%
DACS
69
Dymon Asia Capital (Singapore)
Singapore
$304K +$339K +15,000 New
Jane Street
70
Jane Street
New York
$301K -$120K -5,327 -26%
HKAM
71
Horizon Kinetics Asset Management
New York
$291K – – –
EAM
72
Erste Asset Management
Austria
$284K – – –
Goldman Sachs
73
Goldman Sachs
New York
$281K -$939K -41,543 -75%
Natixis Advisors
74
Natixis Advisors
Massachusetts
$261K +$292K +12,912 New
PNC Financial Services Group
75
PNC Financial Services Group
Pennsylvania
$223K +$74.6K +3,300 +43%
1 2
3
4 5

BCYC Hedge Fund Activity: Q2 2024 in Review

107 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q2 2024, worth a combined $804M — up 5.9% from $759M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new BCYC positions and 14 closed out — a net gain of 12 holders — while 35 added to existing stakes and 25 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $101M. The largest seller was Paradigm Biocapital Advisors, exiting entirely with an estimated $80.8M sold.

  • 107 institutional investors held Bicycle Therapeutics (BCYC) as of Q2 2024, up from 95 in Q1 2024.
  • Funds reported $804M of Bicycle Therapeutics stock for Q2 2024, up 5.9% quarter-over-quarter.
  • 26 funds opened new Bicycle Therapeutics positions in Q2 2024 and 14 closed out, a net change of +12 holders.
  • The largest Bicycle Therapeutics buyer in Q2 2024 was Baker Bros. Advisors, an estimated $101M added.
  • The largest Bicycle Therapeutics seller in Q2 2024 was Paradigm Biocapital Advisors, an estimated $80.8M sold.

Based on aggregated 13F filings for Q2 2024.